Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.

Yang DingLihua CaoLiying ZhuYan HuangChaoshuang LinYuming WangYingxia LiuQiuju ShengShouyun WangJian FanRuochan ChenWeiqiang GanBryan ChenCalvin Qian Pan

Published in: Alimentary pharmacology & therapeutics (2020)

TAF for highly viraemic mothers effectively prevented mother-to-child transmission of hepatitis B. There were no safety concerns for either mothers or infants with 24-28 weeks of follow up.

Keyphrases

hepatitis b virus
mental health
liver failure
quality improvement
gestational age
preterm birth